Bullishcharts

Risky VBI Vaccines trade

Long
NASDAQ:VBIV   VBI Vaccines, Inc.
Entry level on breakout $1.42 = Target price $1.80 = Stop loss $1.32
Speculative breakout and gap fill trade
VBI Vaccines, Inc. is a biopharmaceutical company, which engages in the development of vaccines for infectious disease and immuno-oncology. Its pipeline include HBV Therapeutic,HBV Prophylaxis, CMV Propylaxis, GBM Immunotherapy, MB Immunotherapy, and Zika Propylaxis. The company was founded on July 9, 2015 is headquartered in Cambridge, MA.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.